Terveystalo (TTALO) CMD 2024 summary

Strategic progress, direction, and market positioning

• Achieved turnaround from all-time low profitability in 2023 to exceeding 12.5% EBITDA ahead of schedule, with a structurally stronger and less risky business portfolio.

• Focus shifts from turnaround to confident, balanced growth, leveraging a data-driven integrated care model and digitalization for efficiency, quality, and customer experience.

• Positioned as a leader in a resilient, growing private healthcare market, supported by demographic trends, insurance penetration, and digital transformation, with 5% annual private healthcare market growth.

• Emphasis on organic growth, profit improvement, and optimizing the business portfolio, with no transformational M&A or new country entries planned.

• Clear improvement agendas for Healthcare Services, Portfolio Businesses, and Swedish operations, each with tailored growth and margin targets.

Operational and business area priorities

• Healthcare Services targets above-market growth, 5% annual revenue increase, incremental margin improvement, and best-in-class customer and employee experience.

• Key growth levers include scaling prevention and care paths, deepening insurance partnerships, expanding in selected geographies and specialties, and scaling digital channels.

• Digitalization and AI, including the Ella EMR platform and self-triage tools, are central to productivity gains, with process costs expected to reduce by up to 40% by 2030.

• Portfolio businesses focus on high-margin segments (staffing, digital SaaS, dental), with dental revenues targeted to double and reach industry-leading profitability by 2029.

• Swedish operations are executing a profit improvement program, aiming for break-even in 2025 and exceeding historical profitability by 2027, with focus on mid-sized private clients and market leadership.

Financial guidance and capital allocation

• New financial targets: average 10% annual EPS growth, net debt/EBITA not to exceed 2.5x, and at least 80% of net results distributed as dividends.

• Investment priorities are organic growth (digital and physical assets), with M&A limited to value-adding, synergistic opportunities; no large-scale or transformational deals.

• Margin structure is now balanced across services, with digital and appointment channels profitable and less reliance on diagnostics.

• Cost efficiency and productivity improvements have delivered €10 million in admin savings and 15% reduction in customer service staffing, with further gains expected from AI.

• Over 377 clinics in Finland and 152 in Sweden support broad service delivery and growth ambitions.